## **Core Concept**
Adjuvant radiotherapy in carcinoma of the endometrium (Ca endometrium) is considered in specific situations to improve local control and reduce recurrence rates. The decision to use adjuvant radiotherapy depends on various factors including the stage of cancer, histological type, grade of the tumor, and the presence of high-risk features.

## **Why the Correct Answer is Right**
The correct answer, , typically involves indications such as high-grade tumors (e.g., Grade 2 or 3), tumors with high-risk histology (like serous or clear cell carcinoma), deep myometrial invasion (>50%), or the presence of lymphovascular space invasion. These features increase the risk of local recurrence, making adjuvant radiotherapy a consideration to eliminate microscopic disease that might remain after surgery.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option might not encompass all high-risk features or might be too broad or too narrow in its indication, making it incorrect.
- **Option B:** Similarly, this could be incorrect if it doesn't accurately reflect established guidelines for adjuvant therapy in endometrial cancer.
- **Option D:** This option might include indications that are not standard for adjuvant radiotherapy in Ca endometrium or might omit critical high-risk features.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that the decision for adjuvant radiotherapy in endometrial cancer is often based on the European Society for Medical Oncology (ESMO) or National Comprehensive Cancer Network (NCCN) guidelines, which consider factors like tumor grade, depth of myometrial invasion, and histological type. For instance, patients with stage I endometrial cancer that has high-grade features or deep myometrial invasion are often considered for adjuvant radiotherapy.

## **Correct Answer: C.**